BRAUN
Braun, the one-of-a-kind brand celebrating its 100 years in 2021, has entered a unique collaboration with the Chief Creative Officer and Founder of Off-White™ and Artistic Director of Louis Vuitton Menswear, Virgil Abloh. Today, the design leaders unveil their “functional art” piece with a film on www.Braun.com . A remix track by Virgil Abloh is also available on Abloh’s Soundcloud to bring the Braun ethos of good design to life: “it’s timeless and meant to be appreciated and enjoyed over time.”
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210316005718/en/
The collaboration with Virgil Abloh sees the designer delve into the Braun archives to update and co-curate the 1965 ‘Wandanlage’ hi fi audio wall unit with Braun’s design team into a “functional art” piece. The metallic finish of the 2021 version is a visual manifestation of the parallels between Braun’s polished chrome design aesthetic – such as the 1960 SM3 shaver and 1961 T1 toaster - and the high shine of Virgil Abloh’s cultural and musical references of the past 100 years. These range from the brass and silver instruments of Mamie Smith’s 1930s blues band to the customized polished ‘slabs’ on cars made famous by hip hop stars in the 1980s. By taking a ‘less but better’ approach to the design process, Virgil Abloh and Braun ensure that the original hi fi audio remains the hero of the collaboration – and the technology still functions today as it did back in 1965. The result is a custom build “functional art” piece where design bridges the gap between form and function, with materials that ensure it lasts for the next 100 years.
Virgil Abloh said: “I have always had a deep appreciation for Braun design. For the brand’s 100 years, I jumped at the opportunity to reimagine this iconic Braun product and challenge what we have come to expect from design. The “functional art” piece co-curated with Braun Design not only highlights the original function of the hi fi wall unit that was the best audio of its time, but also the quality and durable materials that are built to last. As a creator, I continue to question how art is perceived in today’s culture. “Functional art” is a lasting legacy of the enduring power of good design that is simple, useful and built to last. In so doing, it advances the frames of design references beyond design ‘purists’ to broader audiences.”
The short film follows Abloh at Farnsworth House – designed and constructed by Ludwig Mies van der Rohe – as he explains his design process behind the reimagined Wandanlage. In a nod to his practice as a DJ, Virgil Abloh has also curated a bespoke remix composition titled ‘Internationalism’ so design ‘purists’ and broader audiences can experience the musical inspiration behind the collaboration.
Virgil said: “The track was conceived in collaboration with The Chopstars, the epochal Houston sound designers; the net result being chopped and screwed jazz classics. The track itself is an audio expression of the thesis in which parallels can be drawn in reference to The Chopstar process, as it relates to the development of our collaboration’s “Functional Art.” The hallmark of the work is rooting the industrial design and existence of the Canon to embody Black culture in a specific way that Houston brand of music specifically achieves - the Chopped not Slopped sonic texture picks up where design leaves off.”
The eclectic track embodies a ‘genre-less’ approach to music, something that Virgil has spoken about before in reference to his musical taste, commenting: “Eclectic, genre-less, longevity, connection, using sound to paint pictures. I always have music on in the background of everything I do. My musical tastes know no boundaries; they don’t fit within a box or a category, very much so in the same way that I or my work don’t just sit in one space. “Internationalism” is a diverse and varied track, yet cohesive in its sentiment. To me, this track exemplifies the Braun ethos of good design – it’s timeless and meant to be appreciated and enjoyed over time.”
To watch the film and find out more information on the Virgil Abloh x Braun collaboration to mark Braun’s 100 years of ‘good design’, please visit www.Braun.com
.
The music track ‘Internationalism’ is available at https://soundcloud.com/vvvirgilabloh
.
- ENDS -
Note to editors:
Braun, a subsidiary of Procter & Gamble founded in Germany in 1921, develops and manufactures a wide variety of small domestic appliances that marry technical innovation, reliable quality and distinctive design. These range from electric shavers and beauty products to hair care appliances. Braun products enjoy worldwide distribution. Please visit www.braun.com for the latest news and in-depth information about the Braun brand.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210316005718/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
Lattice Wins 2025 Global Semiconductor Alliance Award6.12.2025 00:49:00 CET | Press release
‒ Named Most Respected Public Semiconductor Company Achieving $100 Million to $500 Million in Annual Sales ‒ Lattice Semiconductor (NASDAQ: LSCC), the low power programmable leader, today announced that it was selected as ‘Most Respected Public Semiconductor Company’ at the 2025 Global Semiconductor Alliance (GSA) Awards. The GSA awards recognize companies that have demonstrated excellence through their success, vision, strategy, and future opportunities in the industry as determined by votes from GSA members. “We are honored to be recognized by the Global Semiconductor Alliance and our peers as one of 2025’s most respected public semiconductor companies. This recognition reflects the dedication of the Lattice team and the trust of our customers, partners, suppliers, and investors. Looking ahead, we remain laser-focused on driving innovation and strengthening our role as the trusted low power programmable leader for semiconductor and system solutions,” said Ford Tamer, Chief Executive
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
